Outset Medical, Inc. SEC filings OM
Outset Medical, Inc. has 743 filings in SEC EDGAR's recent list, going back to Feb 26, 2010. Its latest annual report, Form 10-K, was filed on Feb 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 28, 2026 | Aug 27, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, Results of operations
|
Jun 17, 2026 | Jun 14, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Officer or director change
|
May 29, 2026 | May 26, 2026 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 4, 2026 |
| S-8 | Employee stock plan registration | Feb 13, 2026 | — |
| 10-K | Annual report | Feb 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Other events
|
Jan 27, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jan 12, 2026 | Jan 7, 2026 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| S-8 | Employee stock plan registration | Jun 5, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Jun 3, 2025 | May 30, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2025 | — |
| DEFA14A | Additional proxy material | May 14, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 14, 2025 | May 10, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| DEF 14A | Proxy statement | Apr 11, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Other events
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Mar 11, 2025 | Mar 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Mar 6, 2025 | Mar 5, 2025 |
| EFFECT | Filing | Feb 28, 2025 | — |
| 424B3 | Prospectus | Feb 28, 2025 | — |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| CORRESP | Letter to the SEC | Feb 26, 2025 | — |
| S-3/A | Filing | Feb 26, 2025 | — |
| 8-K |
Current report
Listing notice, Other events
|
Feb 26, 2025 | Feb 24, 2025 |
| UPLOAD | Letter from the SEC | Feb 21, 2025 | — |
| 8-K |
Current report
Results of operations
|
Feb 19, 2025 | Feb 19, 2025 |
| S-3 | Shelf registration | Feb 13, 2025 | — |
| DEF 14A | Proxy statement | Feb 4, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 24, 2025 | Jan 23, 2025 |
| PRE 14A | Preliminary proxy statement | Jan 24, 2025 | Mar 5, 2025 |
| D | Filing | Jan 21, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Bylaw or fiscal year change
|
Jan 8, 2025 | Jan 7, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Jan 6, 2025 | Jan 3, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 27, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 16, 2024 | Aug 15, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2024 | May 29, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Other events
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Other events
|
May 6, 2024 | May 6, 2024 |
| DEFA14A | Additional proxy material | Apr 11, 2024 | — |
| DEF 14A | Proxy statement | Apr 11, 2024 | May 29, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 13, 2024 | Mar 8, 2024 |
| S-8 | Employee stock plan registration | Feb 22, 2024 | — |
| 10-K | Annual report | Feb 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 21, 2024 | Feb 16, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
New debt
|
Jan 2, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 11, 2023 | Dec 11, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 12, 2023 | Oct 12, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2023 | Aug 2, 2023 |
| 8-K |
Current report
Other events
|
Jul 7, 2023 | Jul 7, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 1, 2023 | May 31, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2023 | — |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 3, 2023 | May 3, 2023 |
| DEFA14A | Additional proxy material | Apr 13, 2023 | — |
| DEF 14A | Proxy statement | Apr 13, 2023 | — |
| S-8 | Employee stock plan registration | Feb 14, 2023 | — |
| 10-K | Annual report | Feb 13, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 13, 2023 | Feb 13, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Nov 4, 2022 | Nov 3, 2022 |
| 10-Q | Quarterly report | Aug 2, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 1, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Jun 13, 2022 | Jun 13, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 1, 2022 | May 31, 2022 |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| DEFA14A | Additional proxy material | Apr 25, 2022 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 25, 2022 | Apr 25, 2022 |
| DEFA14A | Additional proxy material | Apr 14, 2022 | — |
| DEF 14A | Proxy statement | Apr 14, 2022 | May 31, 2022 |
| S-8 | Employee stock plan registration | Feb 23, 2022 | — |
| 10-K | Annual report | Feb 23, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 16, 2022 | Feb 16, 2022 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2021 | Nov 3, 2021 |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 5, 2021 | Jul 30, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jul 1, 2021 | Jun 28, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2021 | Jun 3, 2021 |
| DEFA14A | Additional proxy material | May 24, 2021 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 24, 2021 | May 20, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 5, 2021 | May 5, 2021 |
| DEFA14A | Additional proxy material | Apr 21, 2021 | — |
| DEF 14A | Proxy statement | Apr 21, 2021 | Jun 3, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 13, 2021 | Apr 8, 2021 |
| 424B4 | Prospectus | Apr 12, 2021 | — |
| EFFECT | Filing | Apr 8, 2021 | — |
| S-1MEF | Filing | Apr 8, 2021 | — |
| CORRESP | Letter to the SEC | Apr 6, 2021 | — |
| CORRESP | Letter to the SEC | Apr 6, 2021 | — |
| 8-K |
Current report
Other events
|
Apr 6, 2021 | Apr 6, 2021 |
| S-1 | Registration statement | Apr 6, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2021 | — |
| DRSLTR | Filing | Mar 25, 2021 | — |
| DRS | Filing | Mar 25, 2021 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 24, 2021 | Mar 23, 2021 |
| 10-K | Annual report | Mar 22, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2021 | Mar 9, 2021 |
| 8-K |
Current report
Other events
|
Feb 22, 2021 | Feb 22, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 12, 2021 | Jan 8, 2021 |
| 424B4 | Prospectus | Dec 3, 2020 | — |
| EFFECT | Filing | Dec 2, 2020 | — |
| CORRESP | Letter to the SEC | Nov 30, 2020 | — |
| CORRESP | Letter to the SEC | Nov 30, 2020 | — |
| 8-K |
Current report
Other events
|
Nov 30, 2020 | Nov 30, 2020 |
| S-1 | Registration statement | Nov 30, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 23, 2020 | — |
| DRS | Filing | Nov 19, 2020 | — |
| DRSLTR | Filing | Nov 18, 2020 | — |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 11, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 9, 2020 | Oct 6, 2020 |
| S-8 | Employee stock plan registration | Sep 18, 2020 | — |
| 424B4 | Prospectus | Sep 16, 2020 | — |
| EFFECT | Filing | Sep 14, 2020 | — |
| S-1MEF | Filing | Sep 14, 2020 | — |
| CERT | Filing | Sep 14, 2020 | — |
| 8-A12B | Filing | Sep 11, 2020 | — |
| CORRESP | Letter to the SEC | Sep 10, 2020 | — |
| CORRESP | Letter to the SEC | Sep 10, 2020 | — |
| CORRESP | Letter to the SEC | Sep 9, 2020 | — |
| S-1/A | Amended registration statement | Sep 9, 2020 | — |
| CORRESP | Letter to the SEC | Sep 4, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2020 | — |
| CORRESP | Letter to the SEC | Aug 21, 2020 | — |
| S-1 | Registration statement | Aug 21, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2020 | — |
| DRS/A | Filing | Aug 10, 2020 | — |
| DRSLTR | Filing | Aug 4, 2020 | — |
| DRS/A | Filing | Aug 4, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2020 | — |
| DRS | Filing | Jul 1, 2020 | — |
| D | Filing | Feb 7, 2020 | — |
| D | Filing | Aug 29, 2018 | — |
| D | Filing | Jun 30, 2017 | — |
| D | Filing | May 3, 2017 | — |
| D | Filing | May 19, 2015 | — |
| D/A | Filing | Feb 25, 2011 | — |
| D | Filing | Feb 26, 2010 | — |
Showing 170 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- OM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Jose, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1484612
- Former names
- Home Dialysis Plus, Ltd. (until Feb 25, 2011)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.